NCT05031676

Brief Summary

Opioid free anesthesia is a promising practice in anesthesia. Studies already carried out have compared OFA to an opioid or "opioid anesthesia" (OA) protocol without the use of antihyperalgesic in the OA protocol. Most of the studies currently available have been carried out in Europe, America and a few in Asia under conditions other than those available in precarious situations.That's why we decide to conduct a study to evaluate the effectiveness of an OFA protocol in maxillofacial surgery in Burkina Faso.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2019

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 5, 2020

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

August 7, 2021

Completed
26 days until next milestone

First Posted

Study publicly available on registry

September 2, 2021

Completed
Last Updated

September 2, 2021

Status Verified

August 1, 2021

Enrollment Period

1.3 years

First QC Date

August 7, 2021

Last Update Submit

August 28, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Highest numerical pain score

    The main highest numerical pain score postoperatively

    First two hours postoperatively

Secondary Outcomes (7)

  • Blood pressure

    six minutes after incision

  • Ephedrine

    During anesthesia

  • Wake up

    Time between the end of surgery and extubation

  • Nausea-Vomiting

    During 24 after surgery

  • Highest numerical pain score 24 hours

    The first 24 hours postoperatively

  • +2 more secondary outcomes

Study Arms (2)

group 1

EXPERIMENTAL

Intervention consists at induction : direct intravenous lidocaine 1.5 mg/kg; clonidine 2 μg/kg in 250 ml of isotonic saline, started as soon as the venous route is taken and over a period of approximately 15 minutes; magnesium sulfate 50 mg/kg in the same isotonic saline as clonidine.

Other: opioid free anesthesia

group 2

NO INTERVENTION

In classic induction: fentanyl at a dose of 2 µg/kg. Following induction in all patients consisted of the administration of propofol 2-3 mg/kg in titration, rocuronium 0.6 mg/kg, ketamine 0.5 mg/kg, methylprednisolone 120 mg.

Interventions

Maintenance of anesthesia was done with halothane. The incision was allowed at 1.2 MAC of halothane. This halogen was administered according to the hemodynamic parameters and the habits of the anesthesia team. Before waking up, all the patients benefited from preventive analgesia with 1 g paracetamol combined with 20 mg nefopam by slow intravenous injection over approximately 15 minutes.

group 1

Eligibility Criteria

Age15 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All patients aged between 15 and 65 years, admitted to the central operating room of the hospital for maxillofacial surgery.

You may not qualify if:

  • Known or suspected coronary artery disease on preoperative consultation;
  • Unstable arterial hypertension
  • Insulin-dependent diabetes
  • Second degree atrioventricular block
  • Neuro-vegetative dysautonomia;
  • known allergy or intolerance to a drug of the protocols

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guibla

Bobo-Dioulasso, Houet, Burkina Faso

Location

Related Publications (8)

  • De Kock M. L'anesthésie sans opiacés : anecdote ou nécessité ? Douleur et Analgésie. 2014 sept;27(3):145-148.

    RESULT
  • Beloeil H. Anesthésie sans opiacés. Anesth Réanimation. 2018 may;4(3):215-218.

    RESULT
  • Mulier J. Opioid free general anesthesia: A paradigm shift? Rev Esp Anestesiol Reanim. 2017 Oct;64(8):427-430. doi: 10.1016/j.redar.2017.03.004. Epub 2017 Apr 18. No abstract available. English, Spanish.

  • Parsa FD, Cheng J, Stephan B, Castel N, Kim L, Murariu D, Parsa AA. Bilateral Breast Reduction Without Opioid Analgesics: A Comparative Study. Aesthet Surg J. 2017 Sep 1;37(8):892-899. doi: 10.1093/asj/sjx038.

  • Mansour MA, Mahmoud AA, Geddawy M. Nonopioid versus opioid based general anesthesia technique for bariatric surgery: A randomized double-blind study. Saudi J Anaesth. 2013 Oct;7(4):387-91. doi: 10.4103/1658-354X.121045.

  • Soffin EM, Wetmore DS, Beckman JD, Sheha ED, Vaishnav AS, Albert TJ, Gang CH, Qureshi SA. Opioid-free anesthesia within an enhanced recovery after surgery pathway for minimally invasive lumbar spine surgery: a retrospective matched cohort study. Neurosurg Focus. 2019 Apr 1;46(4):E8. doi: 10.3171/2019.1.FOCUS18645.

  • Bakan M, Umutoglu T, Topuz U, Uysal H, Bayram M, Kadioglu H, Salihoglu Z. [Opioid-free total intravenous anesthesia with propofol, dexmedetomidine and lidocaine infusions for laparoscopic cholecystectomy: a prospective, randomized, double-blinded study]. Rev Bras Anestesiol. 2015 May-Jun;65(3):191-9. doi: 10.1016/j.bjan.2014.05.006. Epub 2014 Nov 1. Portuguese.

  • Toleska M, Dimitrovski A. Is Opioid-Free General Anesthesia More Superior for Postoperative Pain Versus Opioid General Anesthesia in Laparoscopic Cholecystectomy? Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019 Oct 1;40(2):81-87. doi: 10.2478/prilozi-2019-0018.

Study Officials

  • Ismael Guibla, Doctor

    University Hospital Souro Sanou, Burkina Faso

    PRINCIPAL INVESTIGATOR
  • Charles Ilboudo, Doctor

    University Hospital Souro Sanou, Burkina Faso

    STUDY CHAIR
  • Bertille Ki, Professor

    Univesity of Joseph KI-ZERBO, Health sciences institute

    STUDY CHAIR
  • Jean Paul Lechat, Doctor

    Hospital of Charleroi (GHdC), Belgium

    STUDY CHAIR
  • Cheick Bougouma, Doctor

    Univesity of Joseph KI-ZERBO, Health sciences institute

    STUDY CHAIR
  • Alain Traore, Professor

    University of Nazi Boni, Health sciences institute

    STUDY DIRECTOR
  • Flavien Kabore, Professor

    Univesity of Joseph KI-ZERBO, Health sciences institute

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participant does not know the protocol which receive but i
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The patients were randomized during the pre-anesthetic visit in two groups 1 and 2. They were randomized in blocks of four so that, in each block of four patients, there were two patients for the protocol 1 and two patients for the protocol 2.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anaesthesist

Study Record Dates

First Submitted

August 7, 2021

First Posted

September 2, 2021

Study Start

February 15, 2019

Primary Completion

June 15, 2020

Study Completion

October 5, 2020

Last Updated

September 2, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Use number and date to find participant folder. Participant data are confidential.

Locations